Eli Lilly and Company lists 10 executives, led by David A. Ricks, Chairman, President & CEO (age 57). Lucas E. Montarce is the company's Executive VP & CFO (age 48).
In fiscal year 2025 the highest-paid executive was David A. Ricks, Chairman, President & CEO, with total pay of $8.92 million. The 6 executives with reported pay received $24.46 million in all.
The average age of the executives with a known age is 51; the youngest is 40 and the oldest 58.
Titles, ages and pay from company filings; pay for fiscal year 2025.

Chairman, President & CEO
Executive VP & CFO
Chief Scientific & Product Officer and President of Lilly Research Laboratories
Executive VP, General Counsel & Secretary
Executive VP, President of Lilly Oncology & Head of Corporate Business Development
Senior VP of Finance & Chief Accounting Officer
Executive VP and Chief Information & Digital Officer
Senior Vice President of Investor Relations
Executive VP & Chief People Officer
Executive VP and President of Lilly USA & Global Customer Capabilities
| Executive | Title | Age | Total pay |
|---|---|---|---|
| David A. Ricks | Chairman, President & CEO | 57 | $8.92 million |
| Daniel M. Skovronsky M.D., Ph.D. | Chief Scientific & Product Officer and President of Lilly Research Laboratories | 52 | $4.90 million |
| Anat Hakim J.D. | Executive VP, General Counsel & Secretary | 56 | $3.34 million |
| Lucas E. Montarce | Executive VP & CFO | 48 | $3.24 million |
| Jacob S. Van Naarden | Executive VP, President of Lilly Oncology & Head of Corporate Business Development | 40 | $3.00 million |
| Diogo Rau | Executive VP and Chief Information & Digital Officer | 50 | $1.06 million |
Total pay as reported for the fiscal year; it can include salary, bonus and stock awards.
David A. Ricks (Chairman, President & CEO), age 57; total pay in fiscal year 2025 was $8.92 million.
Lucas E. Montarce (Executive VP & CFO), age 48.
David A. Ricks, Chairman, President & CEO, with total pay of $8.92 million in fiscal year 2025.
David A. Ricks (Chairman, President & CEO), Lucas E. Montarce (Executive VP & CFO), Daniel M. Skovronsky M.D., Ph.D. (Chief Scientific & Product Officer and President of Lilly Research Laboratories), Anat Hakim J.D. (Executive VP, General Counsel & Secretary) and Jacob S. Van Naarden (Executive VP, President of Lilly Oncology & Head of Corporate Business Development), and 5 more.